Is a complete PPCB research report available?

No complete published report is available for Propanc Biopharma, Inc. (PPCB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Propanc Biopharma, Inc. (PPCB)

NASDAQ: PPCB · USD

$1.37

-0.08 (-5.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PPCB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.1M
Net income (ttm)	-19.3M
EPS (ttm)	-$32.4
Shares out	2.3M
Volume	15,465
Beta	3.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -19.3M
EPS (ttm): -$32.4
Market cap: 3.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PPCB indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001517681
Company name	Propanc Biopharma, Inc.
Country	Australia
Country code	US
Cusip	74346N800
Employees	2
Employees Change	0%
Employees Change Percent	0
Enterprise value	$3.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US74346N8002
Last refreshed	2026-07-26
Market cap	$3.1M
Market cap category	Nano-Cap
Price	$1.37
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Symbol	PPCB
Website	https://www.propanc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-618.1%
FCF yield	-133.84%
P/B ratio	0.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-19.3M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-9.6M
ROA	-62.31
Roa5y	-1,606.1
ROCE	-169.2
ROE	-127
ROIC	-74.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-75.46%
Cagr1y	-98.78%
Cagr3y	-97.97%
Cagr5y	-97.06%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$14.3M
Cash	$443,702
Current Assets	$8.2M
Current Liabilities	$3.5M
Debt	$573,873
Debt Equity	$0.05
Equity	$10.8M
Interest Coverage	-27.95
Liabilities	$3.5M
Long Term Assets	$6.1M
Long Term Liabilities	$30,267
Net Cash	$-130,171
Net Cash By Market Cap	$-4.17
Net Debt Equity	$0.01
Tangible Book Value	$9.8M
Tangible Book Value Per Share	$11.24
WACC	32.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.37
Net Working Capital	$4.8M
Quick ratio	0.13
Working Capital	$4.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1,295.84%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-98.78%
200-day SMA	10.56
3Y total return	-100%
50-day SMA	1.68
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	3,257,142,857.1
All Time High Change	-100%
All Time High Date	2020-11-19
All Time Low	1.3
All Time Low Change	5.38%
All Time Low Date	2026-06-10
ATR	0.24
Beta	3.3
Beta1y	-0.13
Beta2y	-0.95
Ch YTD	-89.79
High	1.46
High52	270.3
High52 Date	2025-08-01
High52ch	-99.49%
Low	1.35
Low52	1.3
Low52 Date	2026-06-10
Low52ch	5.39%
Ma50ch	-18.45%
Premarket Change Percent	2.76
Premarket Price	$1.49
Premarket Volume	1,618
Price vs 200-day SMA	-87.03%
RSI	38.84
RSI Monthly	44.55
RSI Weekly	32.68
Sharpe ratio	-1.03x
Sortino ratio	-1.63
Total Return	-1,295.84%
Tr YTD	-89.79
Tr1m	-6.8%
Tr1w	-8.05%
Tr3m	-52.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-18.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,940,081%
Float Percent	85.15%
Net Borrowing	-518,660
Shares Insiders	14.85%
Shares Institutions	1.69%
Shares Out	2,278,371
Shares Qo Q	67.87%
Shares Yo Y	1,295.84%
Short Float	0.87%
Short Shares	0.74

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-18.9M
Average Volume	3,044,428.35x
Bv Per Share	11.24
CAPEX	$-4,912
Ch10y	-100
Ch1m	-6.8
Ch1w	-8.05
Ch1y	-98.78
Ch3m	-52.76
Ch3y	-100
Ch5y	-100
Ch6m	-80.43
Change	-5.52%
Change From Open	-4.86
Close	1.45
Days Gap	-0.69
Depreciation Amortization	744
Dollar Volume	21,187.1
Earnings Date	2026-08-14
Earnings Time	bmo
EBIT	$-18.4M
EBITDA	$-18.4M
EPS	$-32.41
F Score	2
FCF	$-4.2M
FCF EV Yield	-128.49x
FCF Per Share	$-1.83
Financing CF	4,546,241
Fiscal Year End	June
Founded	2,007
Investing CF	-4,912
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2026-05-18
Last Split Type	Reverse
Ma150	4.56
Ma150ch	-69.96%
Ma20	1.58
Ma20ch	-13.35%
Net CF	392,942
Next Earnings Date	2026-08-14
Open	1.44
Optionable	No
Position In Range	18.18
Post Close	1.37
Postmarket Change Percent	5.11
Postmarket Price	$1.44
Ppne	50,805
Pre Close	1.45
Price Date	2026-07-24
Ptbv Ratio	0.32
Relative Volume	0.01x
Share Based Comp	14,697,366
Tr6m	-80.43%
Volume	15,465

Propanc Biopharma, Inc. (PPCB)

Coverage state: Market snapshot only — no published research

Generate the first PPCB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · PPCB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PPCB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PPCB

Frequently asked questions